# Five‐Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research

**Authors:** Hermann Eichler, Hagen Bönigk, Susan Halimeh, Christina Hart, Judith Hörner, Robert Klamroth, Ralf Knöfler, Christoph Königs, Thomas Lang, Florian Langer, Wolfgang Miesbach, Johannes Oldenburg, Ramona Oral, Martin Olivieri, Christian Pfrepper, Jan Pilch, Ute Scholz, Werner Streif, Manuela Albisetti

PMC · DOI: 10.1111/hae.70193 · 2025-12-26

## TL;DR

This paper summarizes a 5-year certification program for haemophilia centers in Germany, Austria, and Switzerland, showing high satisfaction and quality improvements.

## Contribution

The paper presents the successful implementation and outcomes of a haemophilia center certification process in three countries.

## Key findings

- 17 comprehensive care centers and 6 treatment centers were certified within five years.
- The audit process resulted in an average of 2.80 nonconformities and 5.96 recommendations per audit.
- Centers reported high satisfaction with the certification process and auditors.

## Abstract

To enhance the treatment quality in haemophilia centres (HC), the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research (GTH) started in 2017 the development of guidelines to define the structural and process quality of HC, essentially related to the EUHANET guidelines.

A certification process for HC located in Germany, Austria and Switzerland started in 2019.

Within the first 5 years, 17 Haemophilia Comprehensive Care Centres (HCCC; ≥ 40 patients with severe HaemA/HaemB or vWD Type 3) and 6 Haemophilia Treatment Centres (HTC; ≥ 10 patients) were certified following a 1‐day on‐site audit performed by two trained haemophilia doctors. Experienced quality management staff supported the audit preparation in the HC. The entire certification process was coordinated by the accredited certification body ClarCert.

In the vast majority of the HCs, the precise specifications of the GTH guidelines in combination with the intensive audit preparation resulted in a mean number of only 2.80 nonconformities per audit (range 0–14). In addition, a mean number of 5.96 (range 2–13) recommendations were documented by the auditors. The feedback of the centres showed a high level of satisfaction with an excellent rating for both the professional auditors and ClarCert as the organizing certification body.

After the successful implementation of the certification process, a certificate is now an essential prerequisite for HC in Germany to conclude separate contracts regarding comprehensive care with health insurance bodies.

## Linked entities

- **Diseases:** von Willebrand disease Type 3 (MONDO:0010191)

## Full-text entities

- **Diseases:** Haemophilia (MESH:D006467), Thrombosis (MESH:D013927), vWD Type 3 (MESH:C536044), Haemostasis (MESH:D020141)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12984471/full.md

---
Source: https://tomesphere.com/paper/PMC12984471